Testing effectiveness (Phase 2)Ended earlyNCT01688336
What this trial is testing
FOLFIRINOX for Unresectable Locally Advanced and Borderline Resectable Pancreatic Cancer
Who this might be right for
Pancreatic Cancer
UNC Lineberger Comprehensive Cancer Center 9